Quarter Period Consolidated Statement Of Income

KYORIN Pharmaceutical Co., Ltd. - Filing #7721845

Concept 2018-04-01 to
2018-06-30
2018-04-01 to
2018-06-30
2018-04-01 to
2018-06-30
2018-04-01 to
2018-06-30
2018-04-01 to
2018-06-30
2017-04-01 to
2017-06-30
2017-04-01 to
2017-06-30
2017-04-01 to
2017-06-30
2017-04-01 to
2017-06-30
2017-04-01 to
2017-06-30
Quarter period consolidated statement of income
Statement of income
Net sales
23,735,000,000 JPY
1,396,000,000 JPY
25,132,000,000 JPY
0 JPY
25,131,000,000 JPY
25,112,000,000 JPY
1,346,000,000 JPY
26,459,000,000 JPY
26,458,000,000 JPY
0 JPY
Cost of sales
11,972,000,000 JPY
11,898,000,000 JPY
Gross profit (loss)
13,158,000,000 JPY
14,560,000,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
11,838,000,000 JPY
11,965,000,000 JPY
Operating profit (loss)
1,261,000,000 JPY
-8,000,000 JPY
1,252,000,000 JPY
67,000,000 JPY
1,320,000,000 JPY
2,512,000,000 JPY
15,000,000 JPY
2,527,000,000 JPY
2,595,000,000 JPY
67,000,000 JPY
Non-operating income
Interest income
7,000,000 JPY
1,000,000 JPY
Dividend income
178,000,000 JPY
168,000,000 JPY
Share of profit of entities accounted for using equity method
6,000,000 JPY
9,000,000 JPY
Non-operating income
287,000,000 JPY
254,000,000 JPY
Non-operating expenses
Interest expenses
6,000,000 JPY
6,000,000 JPY
Non-operating expenses
10,000,000 JPY
44,000,000 JPY
Ordinary profit (loss)
1,596,000,000 JPY
2,805,000,000 JPY
Extraordinary income
Gain on sale of non-current assets
JPY
50,000,000 JPY
Extraordinary income
JPY
627,000,000 JPY
Extraordinary losses
Extraordinary losses
52,000,000 JPY
5,000,000 JPY
Profit (loss) before income taxes
1,544,000,000 JPY
3,426,000,000 JPY
Income taxes - current
151,000,000 JPY
386,000,000 JPY
Income taxes - deferred
315,000,000 JPY
646,000,000 JPY
Income taxes
466,000,000 JPY
1,033,000,000 JPY
Profit (loss)
1,077,000,000 JPY
2,393,000,000 JPY
Profit attributable to
Profit (loss) attributable to owners of parent
1,077,000,000 JPY
2,393,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-824,000,000 JPY
846,000,000 JPY
Foreign currency translation adjustment
-79,000,000 JPY
-49,000,000 JPY
Remeasurements of defined benefit plans, net of tax
132,000,000 JPY
158,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
2,000,000 JPY
2,000,000 JPY
Other comprehensive income
-769,000,000 JPY
958,000,000 JPY
Comprehensive income
307,000,000 JPY
3,351,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
307,000,000 JPY
3,351,000,000 JPY
Comprehensive income attributable to non-controlling interests
JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.